Concepedia

Antibodies against recombinant alpha-galactosidase A in Fabry disease: Subclass analysis and impact on response to treatment

Sanne J. van der Veen, André B. P. Kuilenburg, Carla E. M. Hollak, Paul Kaijen, Jan Voorberg, Mirjam Langeveld

Molecular Genetics and Metabolism · 2018 · 52 citations · 28 references

DOIFull text

Open access

Concepts

References

28

α-Galactosidase A deficiency. Fabry disease

R J Desnick · Medical Entomology and Zoology · 2001 · 581 citations

, , +5

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study

Maarten Arends, Christoph Wanner, Derralynn Hughes et al. · Journal of the American Society of Nephrology · 2016 · 421 citations · Full text

, , +9

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4

Maartje G. Huijbers, Wei Zhang, Rinse Klooster et al. · Proceedings of the National Academy of Sciences · 2013 · 289 citations · Full text

, , +17

Enzyme therapy for Fabry disease: Neutralizing antibodies toward agalsidase alpha and beta

Gabor E. Linthorst, Carla E. M. Hollak, Wilma E. Donker‐Koopman et al. · Kidney International · 2004 · 281 citations

, , +9

The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease

Suhrad G. Banugaria, Sean N. Prater, Yiu-Ki Ng et al. · Genetics in Medicine · 2011 · 251 citations · Full text

, , +15